Cargando…
The incidence of consecutive manifestations in Von Hippel-Lindau disease
Von Hippel-Lindau (VHL) disease is an autosomal dominant rare tumor syndrome characterized by high penetrance. VHL mutation carriers develop numerous manifestations in multiple organs during life. The natural course of development of new and growth of existing VHL-related manifestations is still unc...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560011/ https://www.ncbi.nlm.nih.gov/pubmed/31087189 http://dx.doi.org/10.1007/s10689-019-00131-x |
_version_ | 1783425882416742400 |
---|---|
author | van der Horst-Schrivers, Anouk N. A. Sluiter, Wim J. Kruizinga, Roeliene C. van Leeuwaarde, Rachel S. Giles, Rachel Olderode-Berends, Maran J. W. Links, Thera P. |
author_facet | van der Horst-Schrivers, Anouk N. A. Sluiter, Wim J. Kruizinga, Roeliene C. van Leeuwaarde, Rachel S. Giles, Rachel Olderode-Berends, Maran J. W. Links, Thera P. |
author_sort | van der Horst-Schrivers, Anouk N. A. |
collection | PubMed |
description | Von Hippel-Lindau (VHL) disease is an autosomal dominant rare tumor syndrome characterized by high penetrance. VHL mutation carriers develop numerous manifestations in multiple organs during life. The natural course of development of new and growth of existing VHL-related manifestations is still unclear. In this study we aimed to gain insight into the development of subsequent manifestations in VHL disease. We retrospectively scored each new VHL-related manifestation as detected by standard follow-up (retina, central nervous system, kidneys and pancreas, excluding adrenal and endolymfatic sac manifestations) in 75 VHL mutation carriers. The Kaplan–Meier method was used to plot the cumulative proportions of all consecutive manifestations in each organ against age. The cumulative average number of manifestations in all organs during life was calculated by summating these cumulative proportions. Poisson model parameters were used to calculate average time to the detection of consecutive VHL manifestations in each organ. Consecutive VHL-related kidney and retina manifestations during life occur linearly according to Poisson distribution model. The total number of VHL manifestations rises linearly, with an average of seven VHL-related lesions at age 60 years. The incidence of consecutive VHL-related manifestations is constant during life in VHL mutation carriers. Our data is consistent with the notion that somatic inactivation of the remaining allele (Knudson’s “two-hit” hypothesis) is the determining factor in developing new VHL-related manifestations. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10689-019-00131-x) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6560011 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Springer Netherlands |
record_format | MEDLINE/PubMed |
spelling | pubmed-65600112019-06-26 The incidence of consecutive manifestations in Von Hippel-Lindau disease van der Horst-Schrivers, Anouk N. A. Sluiter, Wim J. Kruizinga, Roeliene C. van Leeuwaarde, Rachel S. Giles, Rachel Olderode-Berends, Maran J. W. Links, Thera P. Fam Cancer Original Article Von Hippel-Lindau (VHL) disease is an autosomal dominant rare tumor syndrome characterized by high penetrance. VHL mutation carriers develop numerous manifestations in multiple organs during life. The natural course of development of new and growth of existing VHL-related manifestations is still unclear. In this study we aimed to gain insight into the development of subsequent manifestations in VHL disease. We retrospectively scored each new VHL-related manifestation as detected by standard follow-up (retina, central nervous system, kidneys and pancreas, excluding adrenal and endolymfatic sac manifestations) in 75 VHL mutation carriers. The Kaplan–Meier method was used to plot the cumulative proportions of all consecutive manifestations in each organ against age. The cumulative average number of manifestations in all organs during life was calculated by summating these cumulative proportions. Poisson model parameters were used to calculate average time to the detection of consecutive VHL manifestations in each organ. Consecutive VHL-related kidney and retina manifestations during life occur linearly according to Poisson distribution model. The total number of VHL manifestations rises linearly, with an average of seven VHL-related lesions at age 60 years. The incidence of consecutive VHL-related manifestations is constant during life in VHL mutation carriers. Our data is consistent with the notion that somatic inactivation of the remaining allele (Knudson’s “two-hit” hypothesis) is the determining factor in developing new VHL-related manifestations. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10689-019-00131-x) contains supplementary material, which is available to authorized users. Springer Netherlands 2019-05-13 2019 /pmc/articles/PMC6560011/ /pubmed/31087189 http://dx.doi.org/10.1007/s10689-019-00131-x Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Article van der Horst-Schrivers, Anouk N. A. Sluiter, Wim J. Kruizinga, Roeliene C. van Leeuwaarde, Rachel S. Giles, Rachel Olderode-Berends, Maran J. W. Links, Thera P. The incidence of consecutive manifestations in Von Hippel-Lindau disease |
title | The incidence of consecutive manifestations in Von Hippel-Lindau disease |
title_full | The incidence of consecutive manifestations in Von Hippel-Lindau disease |
title_fullStr | The incidence of consecutive manifestations in Von Hippel-Lindau disease |
title_full_unstemmed | The incidence of consecutive manifestations in Von Hippel-Lindau disease |
title_short | The incidence of consecutive manifestations in Von Hippel-Lindau disease |
title_sort | incidence of consecutive manifestations in von hippel-lindau disease |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560011/ https://www.ncbi.nlm.nih.gov/pubmed/31087189 http://dx.doi.org/10.1007/s10689-019-00131-x |
work_keys_str_mv | AT vanderhorstschriversanoukna theincidenceofconsecutivemanifestationsinvonhippellindaudisease AT sluiterwimj theincidenceofconsecutivemanifestationsinvonhippellindaudisease AT kruizingaroelienec theincidenceofconsecutivemanifestationsinvonhippellindaudisease AT vanleeuwaarderachels theincidenceofconsecutivemanifestationsinvonhippellindaudisease AT gilesrachel theincidenceofconsecutivemanifestationsinvonhippellindaudisease AT olderodeberendsmaranjw theincidenceofconsecutivemanifestationsinvonhippellindaudisease AT linkstherap theincidenceofconsecutivemanifestationsinvonhippellindaudisease AT vanderhorstschriversanoukna incidenceofconsecutivemanifestationsinvonhippellindaudisease AT sluiterwimj incidenceofconsecutivemanifestationsinvonhippellindaudisease AT kruizingaroelienec incidenceofconsecutivemanifestationsinvonhippellindaudisease AT vanleeuwaarderachels incidenceofconsecutivemanifestationsinvonhippellindaudisease AT gilesrachel incidenceofconsecutivemanifestationsinvonhippellindaudisease AT olderodeberendsmaranjw incidenceofconsecutivemanifestationsinvonhippellindaudisease AT linkstherap incidenceofconsecutivemanifestationsinvonhippellindaudisease |